Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
The Lausanne University Hospital (CHUV) has reported the initial dosing of a patient in a phase II clinical study investigating the sensitivity of PENTIXAFOR (Boclatixafotide) in a cardiovascular and inflammatory setting. It is the first time that…